Product Description
Glycosyltransferase involved in the elongation of O-linked ligands to activate Notch signaling. Possesses fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity.
Biovision | A1406 | Anti-Manic Fringe Antibody DataSheet
Antibody Target: MFNG
Target Alternative Name: Beta-13-N-acetylglucosaminyltransferase manic fringe; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, MFNG
Tag Line: Polyclonal Antibody to detect Manic Fringe in human samples
Category: Signal Transduction
Host: Rabbit
Isotype: Rabbit IgG
Species Reactivities: Human
Immunogen Sequence: KLH-conjugated synthetic peptide encompassing a sequence within the center region of human Manic Fringe
Accession #: O00587
Gene ID: 4242
Appearance: Colorless liquid
Form: Liquid
Concentration:
Formulation: In 0.42% Potassium phosphate; 0.87% Sodium chloride; pH 7.3; 30% glycerol and 0.01% sodium azide
Purification: Affinity purified
Application: WB
Positive Control: WB: HepG2
Application And Usages: WB; 1:500 1:2000
Country of Animal Origin: USA
Country of Manufacture: USA
Usage: For Research Use Only! Not to be used in humans.
Handling: The antibody solution should be gently mixed before use.
Western Blot Verified: Verified
Immunocytochemistry Verified: Not Verified
Immunofluorescence Verified: Not Verified
Immunoprecipitation Verified: Not Verified
FACS Verified: Not Verified
ELISA Verified: Not Verified
ChIP Verified: Not Verified
Dot Blot Verified: Not Verified
Flow Cytometry Verified: Not Verified